A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)

ClinicalTrials.gov ID: NCT06909214

Public ClinicalTrials.gov record NCT06909214. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 18, 2026, 9:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Open-Label, Prospective, Single-Group, Multicenter Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adult Participants With New-Onset Generalized Myasthenia Gravis

Study identification

NCT ID: NCT06909214
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 4
Lead sponsor: argenx; Industry
Enrollment: 30 participants

Conditions and interventions

Conditions

New Onset Generalized Myasthenia Gravis (gMG)

Interventions

Efgartigimod PH20 SC Biological

Biological

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 16, 2025
Primary completion: Jul 31, 2026
Completion: Apr 30, 2027
Last update posted: Mar 9, 2026

2025 – 2027

United States locations

U.S. sites: 18
U.S. states: 11
U.S. cities: 17

Facility	City	State	ZIP	Site status
University of California, San Diego - Altman Clinical and Translational Research Institute (ACTRI)	La Jolla	California	92037	Recruiting
Samir Macwan, M.D., Inc. (S corporation)	Rancho Mirage	California	92270	Recruiting
EZR Research	Boca Raton	Florida	33486	Recruiting
University of Florida Jacksonville	Jacksonville	Florida	32209	Recruiting
Visionary Investigators Network	Miami	Florida	33133	Recruiting
University of California Irvine	Orange	Florida	92868	Recruiting
Medsol Clinical Research Center Inc	Port Charlotte	Florida	33952	Recruiting
Baycare Medical Group	St. Petersburg	Florida	33705	Recruiting
Emory Brain Health Center	Atlanta	Georgia	30329	Recruiting
The Queen's Medical Center - West Oahu	Honolulu	Hawaii	96813	Recruiting
Hawaii Pacific Neuroscience	Honolulu	Hawaii	96817	Recruiting
HSHS Medical Group	O'Fallon	Illinois	62269	Recruiting
UMass Memorial Medical Center	Worcester	Massachusetts	01655	Recruiting
Henry Ford Health System	Detroit	Michigan	48202	Recruiting
Cleveland Clinic	Cleveland	Ohio	44195	Recruiting
Erlanger Neuroscience Institute	Chattanooga	Tennessee	37403	Recruiting
Central Texas Neurology Consultants - Elligo	Round Rock	Texas	78681	Recruiting
Center for Neurological Disorders - Greenfield	Greenfield	Wisconsin	53228-1321	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06909214, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 9, 2026 · Synced May 18, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06909214 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →